1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Lin, D. Tsui, V. Case, D. Yuan, Y.C. Chen, Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 HUMAN MRF-2 DOMAIN, NMR, 11 STRUCTURES US Nat.Struct.Biol. NSBIEW 2024 1072-8368 5 959 964 10.1038/2934 A Novel DNA-Binding Motif Shares Structural Homology to DNA Replication and Repair Nucleases and Polymerases 1998 NE J.Biomol.NMR JBNME9 0800 0925-2738 11 459 460 10.1023/A:1008231900431 Resonance Assignments of the MRF-2 DNA-Binding Domain 1998 10.2210/pdb1ig6/pdb pdb_00001ig6 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12652.646 MODULATOR RECOGNITION FACTOR 2 DNA-BINDING DOMAIN 1 man polymer MRF-2 no no RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRH YERLILPYERFIKGEEDKPLPPIKPRK RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRH YERLILPYERFIKGEEDKPLPPIKPRK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample MRF-2 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 DE3 PLASMID PQE30 database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2001-04-25 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name 2001-05-02 SPRSDE 1BMY is low quality structure of Human MRF-2 Domain RCSB Y RCSB 2001-04-17 REL REL This structure was determined using the restraints derived from NMR experiments (NOE, dihedral angles, hydrogen bonds, residual dipolar coupling constants, etc.) structures with acceptable covalent geometry,structures with the least restraint violations,structures with the lowest energy 100 11 3D_13C-separated_NOESY 3D_15N-separated_NOESY 3D HNHB 3D_15N_TOCSY-HSQC 3D HCCH-TOCSY 2D_PFG-SE-IPAP 100 mM Sodium Phosphate 6.00 ambient 298 K The structures are based on a total of 2478 restraints, 2290 are NOE-derived distance constraints, 74 dihedral angle restraints, 42 distance restraints from hydrogen bonds, 35 residual dipolar coupling constants. torsion angle dynamics 1 closest to the average 0.7 mM MRF-2 U-15N,13C, 100mM PHOSPHATE BUFFER NA, 0.02% NAN3, 5 mM DDT 90% H2O/10% D2O 0.7 mM MRF-2 U-15N,13C, 100mM PHOSPHATE BUFFER NA, 0.02% NAN3, 5 mM DDT 100% D2O Biosym/MSI processing Felix 98.0 Peter Guntert, et al. structure solution DYANA 1.5 Kollman, Case, Merz, Cheatham, Simmerling, Pearlman refinement Amber 7.0 Varian Associates INC collection VNMR 6.1 500 Varian UNITYPLUS ARG 1 n 1 ARG 1 A ALA 2 n 2 ALA 2 A ASP 3 n 3 ASP 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A ALA 6 n 6 ALA 6 A PHE 7 n 7 PHE 7 A LEU 8 n 8 LEU 8 A VAL 9 n 9 VAL 9 A ALA 10 n 10 ALA 10 A LEU 11 n 11 LEU 11 A TYR 12 n 12 TYR 12 A LYS 13 n 13 LYS 13 A TYR 14 n 14 TYR 14 A MET 15 n 15 MET 15 A LYS 16 n 16 LYS 16 A GLU 17 n 17 GLU 17 A ARG 18 n 18 ARG 18 A LYS 19 n 19 LYS 19 A THR 20 n 20 THR 20 A PRO 21 n 21 PRO 21 A ILE 22 n 22 ILE 22 A GLU 23 n 23 GLU 23 A ARG 24 n 24 ARG 24 A ILE 25 n 25 ILE 25 A PRO 26 n 26 PRO 26 A TYR 27 n 27 TYR 27 A LEU 28 n 28 LEU 28 A GLY 29 n 29 GLY 29 A PHE 30 n 30 PHE 30 A LYS 31 n 31 LYS 31 A GLN 32 n 32 GLN 32 A ILE 33 n 33 ILE 33 A ASN 34 n 34 ASN 34 A LEU 35 n 35 LEU 35 A TRP 36 n 36 TRP 36 A THR 37 n 37 THR 37 A MET 38 n 38 MET 38 A PHE 39 n 39 PHE 39 A GLN 40 n 40 GLN 40 A ALA 41 n 41 ALA 41 A ALA 42 n 42 ALA 42 A GLN 43 n 43 GLN 43 A LYS 44 n 44 LYS 44 A LEU 45 n 45 LEU 45 A GLY 46 n 46 GLY 46 A GLY 47 n 47 GLY 47 A TYR 48 n 48 TYR 48 A GLU 49 n 49 GLU 49 A THR 50 n 50 THR 50 A ILE 51 n 51 ILE 51 A THR 52 n 52 THR 52 A ALA 53 n 53 ALA 53 A ARG 54 n 54 ARG 54 A ARG 55 n 55 ARG 55 A GLN 56 n 56 GLN 56 A TRP 57 n 57 TRP 57 A LYS 58 n 58 LYS 58 A HIS 59 n 59 HIS 59 A ILE 60 n 60 ILE 60 A TYR 61 n 61 TYR 61 A ASP 62 n 62 ASP 62 A GLU 63 n 63 GLU 63 A LEU 64 n 64 LEU 64 A GLY 65 n 65 GLY 65 A GLY 66 n 66 GLY 66 A ASN 67 n 67 ASN 67 A PRO 68 n 68 PRO 68 A GLY 69 n 69 GLY 69 A SER 70 n 70 SER 70 A THR 71 n 71 THR 71 A SER 72 n 72 SER 72 A ALA 73 n 73 ALA 73 A ALA 74 n 74 ALA 74 A THR 75 n 75 THR 75 A CYS 76 n 76 CYS 76 A THR 77 n 77 THR 77 A ARG 78 n 78 ARG 78 A ARG 79 n 79 ARG 79 A HIS 80 n 80 HIS 80 A TYR 81 n 81 TYR 81 A GLU 82 n 82 GLU 82 A ARG 83 n 83 ARG 83 A LEU 84 n 84 LEU 84 A ILE 85 n 85 ILE 85 A LEU 86 n 86 LEU 86 A PRO 87 n 87 PRO 87 A TYR 88 n 88 TYR 88 A GLU 89 n 89 GLU 89 A ARG 90 n 90 ARG 90 A PHE 91 n 91 PHE 91 A ILE 92 n 92 ILE 92 A LYS 93 n 93 LYS 93 A GLY 94 n 94 GLY 94 A GLU 95 n 95 GLU 95 A GLU 96 n 96 GLU 96 A ASP 97 n 97 ASP 97 A LYS 98 n 98 LYS 98 A PRO 99 n 99 PRO 99 A LEU 100 n 100 LEU 100 A PRO 101 n 101 PRO 101 A PRO 102 n 102 PRO 102 A ILE 103 n 103 ILE 103 A LYS 104 n 104 LYS 104 A PRO 105 n 105 PRO 105 A ARG 106 n 106 ARG 106 A LYS 107 n 107 LYS 107 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 5 A ARG 78 0.108 SIDE CHAIN 8 A TYR 88 0.062 SIDE CHAIN 4 3.21 0.50 120.30 123.51 A A A NE CZ NH1 ARG ARG ARG 90 90 90 N 5 3.94 0.50 120.30 124.24 A A A NE CZ NH1 ARG ARG ARG 78 78 78 N 6 3.79 0.50 120.30 124.09 A A A NE CZ NH1 ARG ARG ARG 83 83 83 N 6 3.28 0.50 120.30 123.58 A A A NE CZ NH1 ARG ARG ARG 90 90 90 N 7 4.48 0.50 120.30 124.78 A A A NE CZ NH1 ARG ARG ARG 78 78 78 N 8 3.10 0.50 120.30 123.40 A A A NE CZ NH1 ARG ARG ARG 90 90 90 N 9 3.20 0.50 120.30 123.50 A A A NE CZ NH1 ARG ARG ARG 54 54 54 N 9 3.12 0.50 120.30 123.42 A A A NE CZ NH1 ARG ARG ARG 78 78 78 N 11 3.26 0.50 120.30 123.56 A A A NE CZ NH1 ARG ARG ARG 83 83 83 N 1 A LEU 28 -64.35 -71.59 1 A ASN 34 -141.29 51.97 1 A SER 70 -141.87 48.23 1 A ALA 74 64.87 -44.99 1 A ILE 85 -158.01 -21.91 1 A GLU 95 -142.03 22.86 1 A GLU 96 -151.83 -46.40 2 A ARG 18 -68.84 4.55 2 A LYS 19 73.92 34.89 2 A ILE 22 60.23 -34.23 2 A LEU 28 -97.35 48.47 2 A ILE 33 -63.69 99.30 2 A SER 70 -78.15 24.33 2 A ILE 85 -164.05 -21.78 2 A LYS 93 -141.73 -15.02 2 A GLU 96 34.17 82.62 2 A LYS 98 -131.93 -39.07 2 A ILE 103 45.12 29.42 3 A PRO 21 -71.96 22.33 3 A ILE 22 62.09 -20.11 3 A ASN 34 -141.60 42.80 3 A TYR 48 62.08 -45.82 3 A ILE 85 -150.77 -24.13 3 A GLU 96 31.42 48.43 3 A ASP 97 -74.56 30.21 3 A ILE 103 36.97 38.11 3 A LYS 104 -155.52 63.33 4 A ARG 18 -103.37 -77.42 4 A LYS 19 176.06 15.44 4 A PRO 26 -75.98 -168.86 4 A LEU 28 -81.88 36.51 4 A PHE 30 -143.42 -2.88 4 A GLN 32 -78.33 37.87 4 A ILE 33 53.44 71.12 4 A ASN 34 -69.80 64.47 4 A SER 70 -79.61 41.75 4 A ILE 85 -154.92 -23.97 4 A GLU 96 26.78 64.96 4 A LYS 98 36.35 53.45 4 A PRO 102 -50.73 -9.53 4 A PRO 105 -54.36 170.98 5 A PRO 26 -77.05 -142.97 5 A PHE 30 -144.61 -2.18 5 A GLN 32 -78.92 39.40 5 A SER 70 -84.09 47.41 5 A ILE 85 -157.92 -25.35 5 A GLU 96 -154.64 -43.25 5 A LYS 104 -132.94 -36.01 5 A ARG 106 45.66 28.41 6 A ARG 18 -128.76 -71.15 6 A LYS 19 -150.34 -4.84 6 A ILE 22 65.84 -45.35 6 A TYR 27 71.80 177.91 6 A LEU 28 -88.64 30.70 6 A PHE 30 -146.23 -6.83 6 A PRO 68 -58.69 -4.59 6 A SER 72 -170.18 48.55 6 A ALA 74 59.09 -62.72 6 A ILE 85 -156.83 -33.88 6 A GLU 96 -163.72 -31.65 7 A PHE 30 -143.56 18.98 7 A SER 72 -87.92 34.76 7 A ALA 74 63.46 -54.95 7 A ILE 85 -155.88 -27.64 7 A GLU 95 -142.46 19.63 7 A GLU 96 -143.56 -41.81 7 A ASP 97 -98.73 44.78 7 A LYS 98 -47.32 151.85 8 A ARG 18 -127.88 -50.24 8 A LYS 19 -137.69 -32.23 8 A THR 20 -172.70 140.67 8 A GLU 23 -52.42 -9.91 8 A LEU 28 31.90 34.30 8 A PHE 30 -148.06 -5.94 8 A ARG 54 -137.21 -149.87 8 A SER 70 -140.74 38.75 8 A ALA 74 63.29 -35.93 8 A ILE 85 -153.41 -31.30 8 A GLU 96 -155.51 -40.48 8 A PRO 102 -58.26 23.22 8 A PRO 105 -61.89 30.52 8 A ARG 106 50.53 -4.91 9 A LYS 19 71.14 31.27 9 A PRO 21 -76.81 26.73 9 A ILE 22 53.66 -17.28 9 A GLU 23 -56.97 -2.55 9 A ARG 24 -69.70 44.50 9 A ILE 25 -144.78 34.21 9 A TYR 48 59.69 -47.27 9 A ILE 85 -157.50 -26.99 9 A LYS 93 -141.60 -23.11 9 A GLU 95 -143.07 18.51 9 A GLU 96 24.99 66.52 9 A ARG 106 -148.03 -16.34 10 A PRO 21 -48.49 152.18 10 A GLU 23 -61.68 0.48 10 A PHE 30 -150.32 8.67 10 A GLN 32 -75.11 48.27 10 A ILE 33 63.33 62.64 10 A ASN 34 -63.92 62.60 10 A ILE 85 -165.35 -31.93 10 A GLU 96 28.65 51.95 10 A PRO 102 -54.25 -5.56 11 A PRO 26 -78.59 -158.06 11 A LEU 28 -109.94 52.15 11 A PRO 68 -51.65 -8.28 11 A SER 70 -71.36 22.38 11 A ILE 85 -161.63 -31.62 11 A GLU 96 -151.71 -44.01 11 A PRO 99 -79.72 34.22 HUMAN MRF-2 DOMAIN, NMR, 11 STRUCTURES 1 N N A ARG 1 A ARG 1 HELX_P A GLU 17 A GLU 17 1 1 17 A PRO 21 A PRO 21 HELX_P A ILE 25 A ILE 25 5 2 5 A ASN 34 A ASN 34 HELX_P A LEU 45 A LEU 45 1 3 12 A GLY 46 A GLY 46 HELX_P A ARG 55 A ARG 55 1 4 10 A GLN 56 A GLN 56 HELX_P A GLY 65 A GLY 65 1 5 10 A CYS 76 A CYS 76 HELX_P A ILE 85 A ILE 85 1 6 10 A TYR 88 A TYR 88 HELX_P A GLU 96 A GLU 96 1 7 9 DNA BINDING PROTEIN DNA BINDING PROTEIN, MRF-2, DNA-BINDING MOTIF, PROTEIN-DNA INTERACTION ARI5B_HUMAN UNP 1 17 Q14865 RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRH YERLILPYERFIKGEEDKPLPPIKPRK 17 123 1IG6 1 107 Q14865 A 1 1 107 1 P 1